Najjar Peter A, Madenci Arin L, Zogg Cheryl K, Schneider Eric B, Dankers Christian A, Pimentel Marc T, Chabria Amrita S, Goldberg Joel E, Sharma Gaurav, Piazza Gregory, Bleday Ronald, Orgill Dennis P, Kachalia Allen
Department of Surgery, Brigham and Women's Hospital, Boston, MA; Department of Quality and Safety, Brigham and Women's Hospital, Boston, MA; Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, and Harvard TH Chan School of Public Health, Boston, MA.
Department of Surgery, Brigham and Women's Hospital, Boston, MA.
J Am Coll Surg. 2016 Dec;223(6):804-813. doi: 10.1016/j.jamcollsurg.2016.09.010. Epub 2016 Sep 28.
Prophylactic anticoagulation is routinely used in the inpatient setting; however, the risk of venous thromboembolism (VTE) remains elevated after discharge. Extensive evidence and clinical guidelines suggest post-discharge VTE prophylaxis is critical in at-risk populations, but it remains severely underused in practice.
We performed a single-institution retrospective, nonrandomized, pre- and post-intervention analysis of a systematic post-discharge pharmacologic prophylaxis program against the primary end point, which is post-discharge symptomatic VTE. An institutional American College of Surgeons NSQIP dataset was used to identify patients and outcomes. Patients undergoing major abdominal surgery for malignancy or inflammatory bowel disease were eligible for the post-discharge VTE prevention program.
Among 1,043 patients who underwent abdominal surgery for malignancy or inflammatory bowel disease, 800 (77%) were in the pre-intervention cohort and 243 (23%) patients were in the post-intervention cohort. Rates of inpatient VTE did not significantly differ between cohorts (0.7%, n = 6 pre-intervention vs 1.7%, n = 4 post-intervention; p = 0.25). However, compared with the pre-intervention cohort, patients in the post-intervention cohort demonstrated a significantly lower post-discharge VTE rate (2.5%, n = 20 pre-intervention vs 0.0%, n = 0 post-intervention; p < 0.01).
A systematic post-discharge VTE prophylaxis program including provider education, local guideline adaptation, bedside medication delivery, and education for at-risk patients, was associated with significantly fewer post-discharge VTE events.
预防性抗凝在住院患者中常规使用;然而,出院后静脉血栓栓塞症(VTE)的风险仍然较高。大量证据和临床指南表明,出院后VTE预防对于高危人群至关重要,但在实际应用中仍严重未得到充分利用。
我们对一个系统性出院后药物预防计划进行了单机构回顾性、非随机、干预前后分析,该计划针对的主要终点是出院后有症状的VTE。使用美国外科医师学会国家外科质量改进计划(NSQIP)的机构数据集来识别患者和结局。因恶性肿瘤或炎症性肠病接受大型腹部手术的患者符合出院后VTE预防计划的条件。
在1043例因恶性肿瘤或炎症性肠病接受腹部手术的患者中,800例(77%)在干预前队列,243例(23%)患者在干预后队列。各队列间住院期间VTE发生率无显著差异(干预前0.7%,n = 6;干预后1.7%,n = 4;p = 0.25)。然而,与干预前队列相比,干预后队列患者出院后VTE发生率显著更低(干预前2.5%,n = 20;干预后0.0%,n = 0;p < 0.01)。
一个系统性出院后VTE预防计划,包括对医护人员的教育、根据当地指南进行调整、床边给药以及对高危患者的教育,与出院后VTE事件显著减少相关。